Small molecules in oncology

Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of personalized cancer therapy is now growing rapidly, and the progress being made will result in significant changes in the treatment algorithms for cancer patients. Numerous novel targe...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Weitere Verfasser: Martens, Uwe Marc (HerausgeberIn)
Dokumenttyp: Sammelband
Sprache:Englisch
Veröffentlicht: Berlin, Heidelberg s.l. Springer Berlin Heidelberg Imprint: Springer 2014
Ausgabe:2nd ed. 2014
Schriftenreihe:Recent results in cancer research 201
In: Recent results in cancer research (201)

Volumes / Articles: Show Volumes / Articles.
DOI:10.1007/978-3-642-54490-3
Schlagworte:
Online-Zugang:Verlag, Volltext: https://doi.org/10.1007/978-3-642-54490-3
Resolving-System, lizenzpflichtig, Volltext: http://dx.doi.org/10.1007/978-3-642-54490-3
Cover: https://swbplus.bsz-bw.de/bsz405482620cov.jpg
Volltext
Verfasserangaben:edited by Uwe M. Martens

MARC

LEADER 00000cam a22000002c 4500
001 1656295814
003 DE-627
005 20250620182509.0
007 cr uuu---uuuuu
008 140513s2014 gw |||||o 00| ||eng c
020 |a 9783642544903  |9 978-3-642-54490-3 
024 7 |a 10.1007/978-3-642-54490-3  |2 doi 
035 |a (DE-627)1656295814 
035 |a (DE-576)405482620 
035 |a (DE-599)BSZ405482620 
035 |a (OCoLC)891512097 
035 |a (DE-He213)978-3-642-54490-3 
040 |a DE-627  |b ger  |c DE-627  |e rakwb 
041 |a eng 
044 |c XA-DE 
050 0 |a RC254-282 
072 7 |a MJCL  |2 bicssc 
072 7 |a MED062000  |2 bisacsh 
082 0 |a 616.994 
084 |a 33  |2 sdnb 
084 |a 33  |2 sdnb 
084 |a XI 7000  |q SEPA  |2 rvk  |0 (DE-625)rvk/153024:12905 
084 |a XH 3200  |q SEPA  |2 rvk  |0 (DE-625)rvk/152888:12905 
084 |a XH 5590  |q SEPA  |2 rvk  |0 (DE-625)rvk/152914:12999 
084 |a 44.81  |2 bkl 
084 |a 44.38  |2 bkl 
084 |a 42.13  |2 bkl 
245 0 0 |a Small molecules in oncology  |c edited by Uwe M. Martens 
250 |a 2nd ed. 2014 
264 1 |a Berlin, Heidelberg  |a s.l.  |b Springer Berlin Heidelberg  |b Imprint: Springer  |c 2014 
300 |a Online-Ressource (XVI, 417 p. 46 illus., 26 illus. in color, online resource) 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
490 1 |a Recent Results in Cancer Research  |v 201 
490 0 |a SpringerLink  |a Bücher 
500 |a Description based upon print version of record 
505 8 |a Imatinib MesylateErlotinib -- Axitinib (AG-013736) -- Lapatinib -- Sorafenib -- Sunitinib -- Dasatinib -- Nilotinib -- Bosutinib -- Decitabine -- Azacytidine/Azacitidine -- Bortezomib -- Temsirolimus -- Danusertib -- Vismodegib -- Everolimus -- Vemurafenib -- Vandetanib -- Trametinib -- Dabrafenib -- Ponatinib -- Regorafenib -- Cabozantinib -- Revlimid -- Ibrutinib -- Qizartinib -- Ruxolitinib -- Carfilzomib -- Afitinib. 
520 |a Extensive research into the molecular mechanisms of cancer has heralded a new age of targeted therapy. The field of personalized cancer therapy is now growing rapidly, and the progress being made will result in significant changes in the treatment algorithms for cancer patients. Numerous novel targets that are crucial for the survival of cancer cells can be attacked by small molecules such as protein tyrosine kinase inhibitors. This book, written by acknowledged experts, discusses in detail the most recent developments in targeted cancer therapy using small molecules. A wide range of small molecules is covered, including, in addition to tyrosine kinase inhibitors, mTOR, proteasome, and multikinase inhibitors, among others. For each molecule, aspects such as chemical structure, mechanism of action, drug targets, drug interactions, preclinical studies, clinical trials, treatment applications, and toxicity are discussed 
650 0 |a Medicine & Public Health 
650 0 |a Medicine 
650 0 |a Oncology 
650 0 |a Hematology 
650 2 |a Antineoplastic Agents  |x therapeutic use 
650 2 |a Protein Kinase Inhibitors  |x therapeutic use 
650 2 |a Azacitidine  |x therapeutic use 
650 2 |a Neoplasms  |x drug therapy 
655 7 |a Aufsatzsammlung  |0 (DE-588)4143413-4  |0 (DE-627)105605727  |0 (DE-576)209726091  |2 gnd-content 
689 0 0 |d s  |0 (DE-588)4068347-3  |0 (DE-627)104509163  |0 (DE-576)209173599  |a Cytostatikum  |2 gnd 
689 0 1 |d s  |0 (DE-588)4164124-3  |0 (DE-627)105449709  |0 (DE-576)209886323  |a Kleines Molekül  |2 gnd 
689 0 |5 (DE-627) 
700 1 |a Martens, Uwe Marc  |d 1966-  |e Hrsg.  |0 (DE-588)132250608  |0 (DE-627)519857070  |0 (DE-576)299031349  |4 edt 
776 1 |z 9783642544897 
776 0 8 |i Erscheint auch als  |n Druck-Ausgabe  |t Small molecules in oncology  |b 2. ed.  |d Berlin : Springer, 2014  |h XVI, 417 S.  |w (DE-627)777814560  |w (DE-576)407324585  |z 3642544894  |z 9783642544897 
830 0 |a Recent results in cancer research  |v 201  |9 201  |w (DE-627)548128227  |w (DE-576)9548128225  |w (DE-600)2393522-4  |x 2197-6767  |7 am 
856 4 0 |u https://doi.org/10.1007/978-3-642-54490-3  |x Verlag  |3 Volltext 
856 4 0 |u http://dx.doi.org/10.1007/978-3-642-54490-3  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 2 |u https://swbplus.bsz-bw.de/bsz405482620cov.jpg  |m V:DE-576  |m X:springer  |q image/jpeg  |v 20150305121340  |3 Cover 
889 |w (DE-627)784910723 
912 |a ZDB-2-SME  |b 2014 
935 |h GBV  |i ExPruef 
936 r v |a XI 7000  |b Allgemeines  |k Medizin  |k Pharmakologie und Toxikologie  |k Spezielle Pharmakologie und Toxikologie  |k Cytostatika  |k Allgemeines  |0 (DE-627)1271581264  |0 (DE-625)rvk/153024:12905  |0 (DE-576)201581264 
936 r v |a XH 3200  |b Allgemeines  |k Medizin  |k Onkologie  |k Allgemeine Onkologie  |k Allgemeine Tumortherapie  |k Chemotherapie, Hormontherapie, verschiedene Pharmaka , Immuntherapie  |k Allgemeines  |0 (DE-627)1271081849  |0 (DE-625)rvk/152888:12905  |0 (DE-576)201081849 
936 r v |a XH 5590  |b Pharmakologie, Toxikologie  |k Medizin  |k Onkologie  |k Spezielle Onkologie  |k Allgemeines  |k B. Sachschlüssel  |k Unterteilung nach medizinischen Disziplinen  |k Pharmakologie, Toxikologie  |0 (DE-627)127701826X  |0 (DE-625)rvk/152914:12999  |0 (DE-576)20701826X 
936 b k |a 44.81  |j Onkologie  |q SEPA  |0 (DE-627)106409433 
936 b k |a 44.38  |j Pharmakologie  |q SEPA  |0 (DE-627)106409743 
936 b k |a 42.13  |j Molekularbiologie  |q SEPA  |0 (DE-627)106410458 
951 |a BO 
990 |a Kleines Molekül 
990 |a Cytostatikum 
992 |a 20190521 
999 |a KXP-PPN1656295814  |e 3478625688 
BIB |a Y 
SPR |a Y 
JSO |a {"relMultPart":[{"origin":[{"dateIssuedKey":"2006","publisher":"Springer","dateIssuedDisp":"2006-","publisherPlace":"Berlin ; Heidelberg"}],"id":{"eki":["548128227"],"zdb":["2393522-4"],"issn":["2197-6767"]},"physDesc":[{"extent":"Online-Ressource"}],"dispAlt":"Recent results in cancer research","title":[{"title_sort":"Recent results in cancer research","title":"Recent results in cancer research"}],"note":["Gesehen am 25.10.07"],"type":{"media":"Online-Ressource","bibl":"serial"},"disp":"Recent Results in Cancer Research","language":["eng"],"recId":"548128227","pubHistory":["Nachgewiesen 165.2006 -"],"part":{"number":["201"],"number_sort":["201"]}}],"physDesc":[{"extent":"Online-Ressource (XVI, 417 p. 46 illus., 26 illus. in color, online resource)"}],"note":["Description based upon print version of record"],"type":{"bibl":"edited-book","media":"Online-Ressource"},"language":["eng"],"recId":"1656295814","origin":[{"dateIssuedKey":"2014","publisherPlace":"Berlin, Heidelberg ; s.l.","edition":"2nd ed. 2014","editionNo":2,"publisher":"Springer Berlin Heidelberg ; Imprint: Springer","dateIssuedDisp":"2014"}],"title":[{"title_sort":"Small molecules in oncology","title":"Small molecules in oncology"}],"id":{"doi":["10.1007/978-3-642-54490-3"],"eki":["1656295814"],"isbn":["9783642544903"]},"person":[{"given":"Uwe Marc","family":"Martens","role":"edt","display":"Martens, Uwe Marc","roleDisplay":"Hrsg."}],"name":{"displayForm":["edited by Uwe M. Martens"]}} 
SRT |a SMALLMOLEC2014